Kathleen Mcginley - Oct 6, 2021 Form 3 Insider Report for AERIE PHARMACEUTICALS INC (AERI)

Role
CHRO & VP, Corp Services
Signature
/s/ John LaRocca, Attorney-in-Fact for Kathleen McGinley
Stock symbol
AERI
Transactions as of
Oct 6, 2021
Transactions value $
$0
Form type
3
Date filed
10/18/2021, 04:09 PM
Next filing
Feb 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AERI Common Stock 24.9K Oct 6, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AERI Stock Option (right to buy) Oct 6, 2021 Common Stock 75K $31.25 Direct F1
holding AERI Stock Option (right to buy) Oct 6, 2021 Common Stock 22K $14.16 Direct F1
holding AERI Stock Option (right to buy) Oct 6, 2021 Common Stock 14.7K $43.90 Direct F1
holding AERI Stock Option (right to buy) Oct 6, 2021 Common Stock 13.2K $56.25 Direct F2
holding AERI Stock Option (right to buy) Oct 6, 2021 Common Stock 12.5K $46.86 Direct F3
holding AERI Stock Option (right to buy) Oct 6, 2021 Common Stock 12.5K $23.97 Direct F4
holding AERI Stock Option (right to buy) Oct 6, 2021 Common Stock 12.5K $12.71 Direct F5
holding AERI Stock Option (right to buy) Oct 6, 2021 Common Stock 12.5K $16.22 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are fully vested as of the date hereof.
F2 These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of January 30, 2018.
F3 These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of January 30, 2019.
F4 These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of August 14, 2019.
F5 These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of August 14, 2020.
F6 These options have vested, or are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in substantially equal installments on each of the first 48 monthly anniversaries of July 1, 2021.